Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.

about

Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies.

Item

http://www.wikidata.org/entity/Q49792187

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lipid profile and effect of st ...... phase III baricitinib studies.

@en

Lipid profile and effect of st ...... phase III baricitinib studies.

@en-gb

Lipid profile and effect of st ...... phase III baricitinib studies.

@nl

type

Item

label

Lipid profile and effect of st ...... phase III baricitinib studies.

@en

Lipid profile and effect of st ...... phase III baricitinib studies.

@en-gb

Lipid profile and effect of st ...... phase III baricitinib studies.

@nl

prefLabel

Lipid profile and effect of st ...... phase III baricitinib studies.

@en

Lipid profile and effect of st ...... phase III baricitinib studies.

@en-gb

Lipid profile and effect of st ...... phase III baricitinib studies.

@nl

P1154

2-s2.0-85047873374

http://www.w3.org/2001/XMLSchema#string

P1433

Annals of the Rheumatic Diseases

P1476

Lipid profile and effect of st ...... phase III baricitinib studies.

@en

P2093

Chadi Saifan

http://www.w3.org/2001/XMLSchema#string

Douglas E Schlichting

http://www.w3.org/2001/XMLSchema#string

Giacomo Ruotolo

http://www.w3.org/2001/XMLSchema#string

Iain B McInnes

http://www.w3.org/2001/XMLSchema#string

James D Otvos

http://www.w3.org/2001/XMLSchema#string

Jinglin Zhong

http://www.w3.org/2001/XMLSchema#string

Joel M Kremer

http://www.w3.org/2001/XMLSchema#string

Lei Chen

http://www.w3.org/2001/XMLSchema#string

Margery A Connelly

http://www.w3.org/2001/XMLSchema#string

Monika Kurzawa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity

Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

Role of hepatic lipase and endothelial lipase in high-density lipoprotein-mediated reverse cholesterol transport.

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate.

P304

988-995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1136/ANNRHEUMDIS-2017-212461

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paul Emery

P5530

33444908

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101133422

http://www.w3.org/2001/XMLSchema#string

P6366

2789004799

http://www.w3.org/2001/XMLSchema#string

P6409

151184742

http://www.w3.org/2001/XMLSchema#string

P698

29463520

http://www.w3.org/2001/XMLSchema#string

P921

P932

6029633

http://www.w3.org/2001/XMLSchema#string